Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive vs Standard BP Lowering on Out-of-office BP (ESPRIT Ancillary)
NCT05352633Unknown
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Jul 2022
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in hypertension (HTN) (2 arms), sponsored by National Center for Cardiovascular Disease. Primary endpoint: Differences of the mean blood pressure during daytime. Status: unknown.
02
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05352633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05352633.